Suppr超能文献

根据 COL-CAP 概念分类的颈肌张力障碍患者的临床特征,并采用超声引导下肉毒毒素治疗。

Clinical features of cervical dystonia patients classified by the COL-CAP concept and treated with ultrasound-guided botulinum neurotoxin.

机构信息

Department of Neurology, Szent-Györgyi Albert Clinical Centre, Szent-Györgyi Albert Faculty of Medicine, University of Szeged, Szeged.

出版信息

Ideggyogy Sz. 2023 Jan 30;76(1-2):37-45. doi: 10.18071/isz.76.0037.

Abstract

BACKGROUND AND PURPOSE

Cervical dys­tonia (CD) is the most common form of focal dystonias, where the identification of the involved muscles, the determination of optimal botulinum neurotoxin A (BoNT-A) dose per muscle injection, and precise tar­ge­ting may be challenging. The aim of the current study is to compare local centre data with international data, enabling the iden­tification of population and me­tho­do­­lo­gical factors behind the differences, there­by further improvement of the care of Hun­ga­rian patients with CD.

.

METHODS

The data of all consecutive CD patients, who were injected with BoNT-A at the botulinum neurotoxin outpatient clinic at the Department of Neurology, University of Szeged between 11 August and 21 Sep­tember 2021, were retrospectively col­lected and analysed in a cross-sectional manner. The frequency of the involved muscles, determined by the application of the collum-caput (COL-CAP) concept, and the parameters for the BoNT-A formulations, injected via ultrasound (US)-guidance, were calculated and compared with available international data.

.

RESULTS

In the current study, 58 patients (19 males and 39 females) were involved with mean age of 58.4 (± SD 13.6, range 24-81) years. The most common subtype was torticaput (29.3%). Tremor affected 24.1% of patients. The most injected muscles were trapezius (56.9% of all cases), followed by the levator scapulae (51.7%), splenius capitis (48.3%), sternocleidomastoid (32.8%), and semispinalis capitis (22.4%). The injected mean doses per patient were 117 ± SD 38.5 (range: 50-180) units for onaBoNT-A, 118 ± SD 29.8 (range: 80-180) units for incoBoNT-A, and 405 ± SD 162 (range: 100-750 units) for aboBoNT-A.

.

CONCLUSION

Although there were several similarities between the results of the current and the multicentre studies, all were carried out using the COL-CAP concept and US-guided BoNT-A injections, authors should pay attention to better distinction of torti-forms and the more frequent injection of especially the obliquus capitis inferior, mainly in cases with no-no tremor.

.
摘要

背景与目的

颈肌张力障碍(CD)是局灶性肌张力障碍中最常见的一种,在这种疾病中,确定受累肌肉、每块肌肉注射的最佳肉毒毒素 A(BoNT-A)剂量以及精确的靶向可能具有挑战性。本研究的目的是比较本地中心数据与国际数据,以确定人群差异背后的人口统计学和方法学因素,从而进一步改善匈牙利 CD 患者的护理。

.

方法

在 2021 年 8 月 11 日至 9 月 21 日期间,我们在塞格德大学神经病学系的肉毒毒素门诊对所有连续接受 BoNT-A 注射的 CD 患者进行了回顾性横断面研究。应用 collum-caput(COL-CAP)概念确定受累肌肉的频率,并根据超声(US)引导下注射的 BoNT-A 制剂参数进行计算,并与可用的国际数据进行比较。

.

结果

在本研究中,共有 58 名患者(19 名男性和 39 名女性)参与,平均年龄为 58.4(±SD 13.6,范围 24-81)岁。最常见的亚型是 torticaput(29.3%)。震颤影响了 24.1%的患者。最常注射的肌肉是斜方肌(56.9%的病例),其次是肩胛提肌(51.7%)、头夹肌(48.3%)、胸锁乳突肌(32.8%)和头半棘肌(22.4%)。每位患者的平均注射剂量为 onaBoNT-A 为 117 ± SD 38.5(范围:50-180)单位,incoBoNT-A 为 118 ± SD 29.8(范围:80-180)单位,aboBoNT-A 为 405 ± SD 162(范围:100-750 单位)。

.

结论

尽管当前和多中心研究的结果存在一些相似之处,但两者均采用 COL-CAP 概念和 US 引导下的 BoNT-A 注射进行,作者应注意更好地区分 torti-forms,并更频繁地注射特别是下斜方肌,主要针对无震颤的病例。

.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验